A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/18544172

Download in:

View as

General Info

PMID
18544172